Tag: cancer
-
Implanted Tissue Shown to Produce Thyroid Hormones
In a preclinical test, thyroid tissue earlier removed from lab animals was re-implanted in a protective pouch, which generates production of key hormones by the animals.
-
Grocery Chain Offering Sites for Cancer Biomarker Trial
The Kroger grocery store chain in the U.S. is establishing a clinical trial network through its urgent care centers, starting with a study of microbiome cancer biomarkers.
-
Nanotech Enzyme Process Boosts T-Cell Cancer Therapies
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells.
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.
-
Biotech Alliance Creating Circular RNA Cancer Drug
A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment.
-
Protein Chemistry Biotech Gains Collaboration, Venture Funds
An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech.
-
Peptide Discovery Company to Gain $3.3B in Licensing Deals
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion.
-
Infographic – Cancer Start-Up Venture Funds Decline
Funding for new enterprises creating products and services that treat or detect cancer fell more than 40 percent from last year.
-
Trial Shows Gel Clears Common Skin Cancer Wounds
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors.
-
Trial Testing Ultrasound for Brain Cancer Liquid Biopsies
A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer.